Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Research & Development (2017 - 2025)

Neuronetics (STIM) has disclosed Research & Development for 9 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 71.14% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, down 48.45% year-over-year, with the annual reading at $6.6 million for FY2025, 48.45% down from the prior year.
  • Research & Development for Q4 2025 was $1.7 million at Neuronetics, up from $1.5 million in the prior quarter.
  • The five-year high for Research & Development was $5.8 million in Q4 2024, with the low at $1.5 million in Q3 2025.
  • Average Research & Development over 5 years is $2.3 million, with a median of $2.2 million recorded in 2023.
  • The sharpest move saw Research & Development soared 161.53% in 2024, then crashed 71.14% in 2025.
  • Over 5 years, Research & Development stood at $1.7 million in 2021, then surged by 79.99% to $3.1 million in 2022, then fell by 29.69% to $2.2 million in 2023, then skyrocketed by 161.53% to $5.8 million in 2024, then plummeted by 71.14% to $1.7 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $1.7 million, $1.5 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.